Literature DB >> 3143266

Postoperative instillation of low-dose mitomycin C in the treatment of primary pterygium.

S Hayasaka1, S Noda, Y Yamamoto, T Setogawa.   

Abstract

Eighty patients (99 eyes) with primary pterygia were treated with excision, with or without additional therapy, and were followed up for three to eight years after treatment. Of 29 eyes that underwent excision and postoperative instillation of 0.02% mitomycin C, there were only two recurrences. The other eyes were treated with excision only, excision and radiation, or excision and 0.04% mitomycin C. Instillation of 0.02% mitomycin C reduced the recurrence rate significantly (P less than .01). Only one of the 29 eyes (3%) treated with excision and 0.02% mitomycin C had a complication, the lowest rate of all groups postoperatively. We found the postoperative instillation of 0.02% mitomycin C, twice a day for five days, to be effective and safe in the treatment of primary pterygium.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143266     DOI: 10.1016/0002-9394(88)90706-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  41 in total

1.  Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium.

Authors:  S E Ti; S P Chee; K B Dear; D T Tan
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

2.  Serious corneoscleral complications after pterygium excision with mitomycin C.

Authors:  B Safianik; I Ben-Zion; H J Garzozi
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery.

Authors:  S Amano; Y Motoyama; T Oshika; S Eguchi; K Eguchi
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

4.  Mitomycin C dissolved in a reversible thermosetting gel: target tissue concentrations in the rabbit eye.

Authors:  K Ichien; T Yamamoto; Y Kitazawa; A Oguri; H Ando; Y Kondo
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

5.  Comparison of mitomycin C and limbal-conjunctival autograft in the prevention of pterygial recurrence in Turkish patients: A one-year, randomized, assessor-masked, controlled trial.

Authors:  Seyhmus Ari; Ihsan Caca; Zennure Özdemir Yildiz; Yildirim Bayezit Sakalar; Eyüp Dogan
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

6.  Protracted ruthenium treatment of recurrent pterygium.

Authors:  Y Robert; L Pauli; P Gysin; B Gloor; P Hendrickson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

7.  Postoperative subconjunctival 5-fluorouracil in the management of recurring pterygium.

Authors:  Anupama Pherwani; Vipul Vakil; Habibullah Eatamadi; Ravinder Singh; Harminder S Dua
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

8.  The study of etiological and demographic characteristics of pterygium recurrence: a consecutive case series study from Pakistan.

Authors:  P Salim Mahar; Nabeel Manzar
Journal:  Int Ophthalmol       Date:  2013-06-18       Impact factor: 2.031

9.  Mitomycin C for pterygium: long term evaluation.

Authors:  F Raiskup; A Solomon; D Landau; M Ilsar; J Frucht-Pery
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

10.  Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium.

Authors:  R Rachmiel; H Leiba; S Levartovsky
Journal:  Br J Ophthalmol       Date:  1995-03       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.